查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1860304

立體定位手術設備市場：2025-2032年全球預測（按最終用戶、技術、產品、類型和應用分類）

Stereotactic Surgery Devices Market by End User, Technology, Product, Type, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，立體定位手術設備市場將成長至 406.5 億美元，複合年成長率為 5.50%。

關鍵市場統計數據
基準年 2024 264.7億美元
預計年份：2025年 279.6億美元
預測年份 2032 406.5億美元
複合年成長率 (%) 5.50%

高精度導航、整合影像工作流程和臨床醫生主導的模組化設計正在重新定義各個外科專科對立體定位設備的期望。

立體定位手術設備融合了精密工程、影像融合和神經外科創新技術。過去十年，導航演算法、微型追蹤感測器和機器人輔助技術的進步，重塑了臨床醫生對手術精確度、術中引導和流程效率的期望。這些設備旨在實現腦部、耳鼻喉和脊椎手術的精準靶點定位，如今，評估這些設備不僅關注其技術性能，還日益重視互通性、消毒便捷性以及對手術室效率的影響。

臨床醫生和採購負責人現在要求提供證據，證明其具有可重複的準確性，並能切實縮短手術時間和減少併發症。因此，醫療器材的研發優先考慮模組化架構，以便在不中斷既定臨床通訊協定的情況下逐步升級硬體模組和軟體。這促使醫院、門診手術中心和專科診所重新評估其採購標準，更加重視生命週期靈活性和整體擁有成本。同時，研究機構和臨床負責人繼續透過多中心研究和註冊登記來完善適應症和手術流程的最佳實踐。

追蹤技術、機器人技術和軟體檢驗工作流程的整合正在推動產品開發和臨床應用模式的根本性轉變

由於技術、臨床和商業性因素的共同作用，立體定位手術器械領域正經歷變革性的轉變。首先，光學和電磁追蹤技術的成熟拓展了無框架手術的應用範圍，實現了微創手術流程，並提高了患者的舒適度。同時，機器人輔助技術的興起帶來了致動器精度和外科醫生與器械交互方式的新範式，使得討論的重點從器械的替代轉向了手術能力的拓展。

其次，軟體定義功能已成為差異化優勢。高階規劃套件、即時註冊更新和機器輔助軌跡最佳化正從輔助工具轉變為導航生態系統的核心組件。這種轉變迫使製造商優先考慮軟體檢驗、使用者介面人體工學和安全的資料架構。第三，醫療設備軟體的報銷政策和不斷變化的監管路徑正在影響產品藍圖，並促使企業儘早與支付方和監管機構相關人員溝通。隨著這些變化的共同作用，競爭優勢如今取決於能否提供端到端的臨床價值，這種價值結合了硬體精度、檢驗的軟體以及為醫療服務提供者帶來的顯著營運效益。

關稅驅動的供應鏈重組和區域製造地轉移已經重新定義了2025年的籌資策略和醫療設備設計重點。

2025年美國關稅政策為立體定位手術設備及其零件的全球供應鏈帶來了新的貿易摩擦。對精密電子產品、追蹤感測器和某些機器人子系統徵收的進口關稅增加了依賴跨境採購的製造商的成本。為應對這項挑戰，多家公司加快了關鍵供應鏈的本地化進程，修訂了供應商契約，並探索了近岸外包策略，以降低關稅波動帶來的風險。這些調整導致前置作業時間出現短期中斷，並促使採購部門重新評估其庫存策略。

面對不斷上漲的投入成本，製造商採取了有針對性的策略，將部分成本內部消化，同時透過與高階功能相關的選擇性價格調整將其他成本轉嫁出去。臨床客戶和經銷商也隨之調整，優先採購那些能夠帶來可衡量的臨床效率提升或支援長期服務協議的產品。隨著時間的推移，關稅主導的趨勢促使產品設計創新，減少了對受關稅影響部件的依賴，並促進了以區域製造地為中心的夥伴關係，從而保障市場准入並控制營運利潤率。因此，如今的策略討論通常將貿易政策情境作為供應鏈規劃和產品生命週期決策的關鍵因素。

一個將最終用戶、技術、產品、設備類型和臨床應用連結起來的多維細分框架揭示了不同臨床環境和流程下的獨特價值促進因素。

基於最終用戶的細分將醫療機構分為門診手術中心、醫院和專科診所。門診手術中心進一步細分為醫院附屬機構和獨立機構，而醫院則按私立、公立和教學醫院進行分類。這種結構突顯了醫療環境對採購週期、資本規劃和臨床容量需求的影響，並突顯了不同機構採用新模式的時間差異。具體而言，獨立門診中心往往優先考慮快速周轉率和成本效益，而教學醫院則更注重與培訓和研究計畫的整合。

技術細分將電磁追蹤和光學追蹤分開，電磁追蹤可細分為高頻和低頻方法，而光學追蹤則可分為基於紅外線和基於雷射的實現方式。這些技術區別至關重要，因為頻率特性、視線限制以及對術中干擾的敏感度決定了特定手術的選擇標準。這可以決定醫療機構是選擇具有強大且不受視線限制性能的電磁解決方案，還是選擇在最佳視線條件下提供高解析度可視化的光學系統。

產品分類包括配件、導航系統和機器人系統。導航系統又細分為硬體模組和軟體元件，而機器人系統則分為主動式和被動式架構。硬體模組化和軟體功能之間的相互作用決定了升級路徑和長期服務關係。同時，主動式和被動式機器人輔助的選擇反映了臨床理念中關於自動化程度和外科醫師控制的重點。

類型分類將系統分為框架系統和無框架系統。有框架系統僅限於立體定位框架，而無框架系統又分為有標記系統和無標記系統。這種分類會影響患者體驗和手術物流，因為有框架系統的工作流程需要頻繁的術前固定和影像校準，而無框架和無標記系統可以簡化患者準備工作，並縮短某些手術的麻醉時間。

應用領域分為神經外科、耳鼻喉科和脊椎外科。神經外科又細分為深部腦部刺激和腫瘤切除術，耳鼻喉科手術細分為鼻竇手術和腫瘤手術，脊椎外科細分為減壓術和融合術。這些臨床細分決定了不同的器械要求，取決於目標解剖結構、所需的軌跡精度以及術中適應性，進而影響檢驗研究、外科醫生培訓計劃和上市後證據生成策略。

區域採納路徑反映了美洲、歐洲、中東和非洲以及亞太地區的基礎設施成熟度、報銷模式和區域證據優先事項。

美洲、歐洲/中東/非洲和亞太地區立體定位手術設備的區域趨勢呈現出不同的需求促進因素，這些因素受到醫療基礎設施成熟度、報銷標準和當地法規環境的影響。在美洲，大型三級醫療中心和設備創新者的集中推動了先進導航和機器人系統的早期應用，而門診手術中心則擴大採用無框架和無標記解決方案，以支持高通量擇期手術。在北美，從研究階段到常規應用階段的過渡通常是由可證實的流程效率和與手術報銷系統的契合度所驅動的。

在歐洲、中東和非洲地區，不同的監管路徑和醫院資金籌措模式造就了多樣化的應用模式。一些國家強調成本效益高的採購方式，並提供包含培訓和長期服務的優質套餐；而領先的追蹤技術和機器人混合系統則經常在西歐的卓越醫療中心進行試點。在亞太地區，醫院的快速擴張、對診斷成像能力的投資以及不斷增強的本地製造能力，正在加速公立和私立醫院，特別是教學醫院，將立體定向平台整合到不斷發展的專科項目中，從而推動相關技術的應用。在所有地區，臨床夥伴關係和本地證據的累積仍然是實現持續應用和獲得支付方認可的關鍵。

在競爭激烈的環境中，整合導航生態系統、策略夥伴關係和生命週期服務貨幣化是設備製造商的關鍵差異化因素。

立體定位設備領域的主要企業正致力於在硬體、軟體和服務這一連續體上進行策略定位，主要企業投資於整合導航生態系統而非獨立設備。一些成熟的設備製造商正透過有針對性的收購來擴展其產品組合，從而獲得軟體規劃套件、感測器技術和配套的機器人模組。同時，敏捷的創新者則專注於利用低成本、高精度的追蹤技術和創新的無標記配準演算法來實現差異化。這種競爭環境促使人們更加重視軟體版本的互通性、合規性以及能夠縮短臨床醫生學習曲線的完善培訓計劃。

醫療設備製造商、影像供應商和醫療系統之間的合作日益普遍，從而能夠共同開發檢驗的工作流程和進行真實世界證據研究。服務模式正從傳統的保固和維護協議演變為與手術結果和運作保證掛鉤的價值導向合約。對於新參與企業而言，成功往往取決於在特定應用領域展現出明顯的臨床優勢（例如，深部腦部刺激中的軌跡精度或鼻竇手術中導航時間的縮短），而現有企業則利用規模經濟、全球服務網路和已建立的醫院關係來保障其現有基本客群的收入來源。投資者和策略夥伴正著眼於軟體智慧財產權、感測器融合能​​力和生命週期商業化戰略方面的差異化優勢。

優先考慮模組化設計、可靠的臨床證據、靈活的商業模式和供應鏈韌性，以推動產品應用並保障長期價值。

產業領導者若想從立體定位手術系統中獲取臨床和商業性價值，應優先採取一系列切實可行的步驟，使產品開發與臨床工作流程和機構採購行為保持一致。首先，投資於模組化架構，以便對硬體模組和軟體應用進行增量升級。這使客戶能夠在引入新功能的同時，保護其現有投資。其次，透過多中心研究，重點在於手術效率、併發症減少和可重複的精確性，從而累積更有力的臨床證據。這些數據將有助於採購談判，並加速臨床醫生對該系統的應用。第三，發展靈活的商業模式，結合資本投入、訂閱和按績效付費等要素，以適應不同醫院和門診中心的預算。

此外，我們將專注於加強供應鏈韌性，並透過考慮二級供應商資格和關鍵零件的區域化生產來規避貿易中斷風險。我們將強化上市後支援和培訓項目，採用基於模擬的課程體系，以縮短學習曲線並提高手術效率。最後，我們將積極與監管機構和支付方溝通，為軟體更新提供清晰的路徑，並明確闡述導航式醫療服務的臨床和經濟價值。透過共同落實這些建議，企業領導者可以最大限度地減少實施阻力，保障利潤，並將技術差異化轉化為可衡量的臨床效益。

臨床和營運方面的研究結果透過嚴格的證據分析檢驗，該分析整合了臨床醫生訪談、醫療設備文件、監管記錄和技術評估。

該研究結合了對臨床醫生、採購人員和行業高管的定性訪談，以及對監管申報文件、同行評審的臨床研究和產品文獻的系統性回顧。主要資訊來源包括與神經外科醫生、耳鼻喉科醫生、脊椎外科醫生和手術室管理人員的半結構化討論，以了解實際工作流程的限制、推廣障礙和所需功能集。次要分析包括設備手冊、監管核准和臨床試驗通訊協定，以檢驗技術聲明並了解證據產生時間表。在整個研究過程中，資訊來源的三角驗證確保了報告的臨床結果與設備規格之間的一致性。

我們的分析方法結合了訪談記錄的主題編碼，以識別技術採納促進因素，並運用技術評估框架評估追蹤準確性、延遲和整合複雜性。供應鏈分析揭示了貿易政策變化暴露的關鍵組件依賴關係和物流漏洞。我們仔細交叉引用了公開的監管文件和同行評審的臨床文獻，以識別證據缺口，並確定未來臨床評估的優先領域，同時推薦在醫院環境中實施切實可行的檢驗方法。

整合的臨床平台、檢驗的工作流程和強大的交付策略將決定哪些創新能夠轉化為持續的臨床和商業性成功。

立體定位設備正從獨立工具轉型為整合式臨床平台，這些平台必須具備可驗證的手術價值、無縫的互通性以及穩健的供應鏈策略。技術融合、軟體賦能設備監管要求的不斷變化以及貿易相關的供應鏈變革，迫使相關人員在創新與服務、培訓和長期升級等實際考慮之間尋求平衡。臨床醫生越來越傾向於選擇能夠融入現有影像生態系統並顯著降低手術複雜性和變異性的設備。

對於製造商而言，未來的發展方向在於加大對臨床證據的投入，制定靈活的商業契約，並加強區域供應鏈網路以降低政策衝擊。對於醫療服務提供者而言，優先考慮生命週期價值和整體工作流程影響而非初始價格來製定採購決策，可以改善患者預後並提高營運效率。簡而言之，設備開發商、醫療服務提供者和政策制定者必須攜手合作，確保技術進步能夠轉化為更安全、更便利、更經濟高效的立體定位治療。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧驅動的成像和導航系統整合到立體定位手術中，實現即時手術引導。
  • 開發具有觸覺回饋的新一代機械臂，以提高神經外科手術的精確度
  • 推出用於標靶治療運動障礙和癲癇的微創立體定向平台
  • 新興的雲端基礎的數據管理解決方案可用於立體定向手術中的協作規劃和結果追蹤
  • MRI相容於立體定位手術器械的廣泛應用，使得術中影像診斷成為可能，並提高了手術精確度。
  • 擴增實境與立體定位框架相結合，正擴大用於改善神經外科手術中的軌跡可視化。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 立體定位外科器械市場（按最終用戶分類）

  • 門診手術中心
    • 院內門診手術中心
    • 獨立門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院
    • 教學醫院
  • 專科診所

第9章 立體定位外科器械市場：依技術分類

  • 電磁追蹤
    • 高頻
    • 低頻
  • 光學追蹤
    • 基於紅外線的
    • 雷射基座

第10章 立體定位外科器械市場：依產品分類

  • 配件
  • 導航系統
    • 硬體模組
    • 軟體
  • 機器人系統
    • 主動系統
    • 被動系統

第11章 立體定位外科器械市場（按類型分類）

  • 基於框架的設備
    • 立體定位框架
  • 無邊框設備
    • 基於標記的
    • 無標記

第12章 立體定位外科器械市場：依應用領域分類

  • 腦外科手術
    • 深部腦部刺激
    • 腫瘤切除
  • 耳鼻喉科手術
    • 鼻竇手術
    • 腫瘤手術
  • 脊椎手術
    • 減壓手術
    • 融合

第13章 立體定位外科器械市場：按地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 立體定位外科器械市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國立體定位外科器械市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Elekta AB（publ）
    • Brainlab AG
    • Renishaw plc
    • Synaptive Medical, Inc.
    • Monteris Medical Corporation
    • iSYS Medizintechnik GmbH
    • FHC, Inc.
Product Code: MRR-DD0700E81DCF

The Stereotactic Surgery Devices Market is projected to grow by USD 40.65 billion at a CAGR of 5.50% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 26.47 billion
Estimated Year [2025] USD 27.96 billion
Forecast Year [2032] USD 40.65 billion
CAGR (%) 5.50%

High-precision navigation, integrated imaging workflows, and clinician-driven modularity are redefining expectations for stereotactic surgery devices across surgical specialties

Stereotactic surgery devices are at the intersection of precision engineering, imaging integration, and neurosurgical innovation. Over the last decade, advances in navigation algorithms, miniaturized tracking sensors, and robotic assistance have reshaped clinician expectations for accuracy, intraoperative guidance, and workflow efficiency. These devices, designed to enable precise target localization for interventions in the brain, ear, nose and throat, and spine, are increasingly evaluated not only on technical performance but also on interoperability with existing imaging platforms, ease of sterilization, and throughput implications for operating room schedules.

Clinicians and procurement leaders now demand evidence of reproducible accuracy and demonstrable reductions in procedure time and complications. Consequently, device development has prioritized modular architectures that allow incremental upgrades to hardware modules and software without disrupting established clinical protocols. As a result, hospitals, ambulatory surgical centers, and specialty clinics are reconsidering procurement criteria to emphasize lifecycle flexibility and total cost of ownership, while research institutions and clinical leaders continue to refine indications and procedural best practices through multi-center collaborations and registries.

Convergence of tracking, robotics, and software-validated workflows is driving a fundamental reorientation of product development and clinical adoption patterns

The landscape of stereotactic surgery devices is undergoing transformative shifts driven by converging technological, clinical, and commercial forces. First, the maturation of optical and electromagnetic tracking technologies has expanded the procedural envelope for frameless approaches, enabling less invasive workflows and improved patient comfort. Simultaneously, the rise of robotic assistance has introduced new paradigms in actuator precision and surgeon-device collaboration, shifting the conversation from device replacement to augmentation of surgical capability.

Second, software-defined functionality has become a differentiator. Advanced planning suites, real-time registration updates, and machine-assisted trajectory optimization are migrating from adjunct tools to core components of navigation ecosystems. This transition compels manufacturers to prioritize software validation, user interface ergonomics, and secure data architectures. Third, reimbursement policies and evolving regulatory pathways for software as a medical device are influencing product roadmaps, prompting earlier stakeholder engagement with payers and regulators. Together, these shifts mean that competitive advantage now resides in the ability to deliver end-to-end clinical value-combining hardware precision, validated software, and clear operational benefits for care providers.

Tariff-induced supply chain recalibrations and regional manufacturing shifts reshaped procurement strategies and device design priorities throughout 2025

The imposition of tariffs in the United States during 2025 introduced a layer of trade friction that affected the global supply chain for stereotactic surgery devices and their subcomponents. Import duties on precision electronics, tracking sensors, and certain robotic subsystems increased costs for manufacturers who relied on cross-border component sourcing. In response, several firms accelerated localization of critical supply lines, re-evaluated supplier contracts, and explored nearshoring strategies to mitigate exposure to tariff volatility. These adjustments triggered short-term disruptions in lead times and prompted a reassessment of inventory strategies within procurement organizations.

Manufacturers facing higher input costs made targeted decisions to absorb some expenses while passing others through in the form of selective price adjustments tied to premium feature sets. Clinical customers and distributors adapted by prioritizing purchases that delivered measurable clinical efficiencies or that supported long-term service agreements. Over time, the tariff-driven dynamics spurred innovation in product design to reduce reliance on tariffed components, and they incentivized partnerships focused on regional manufacturing hubs to protect access and control operating margins. As a consequence, strategy conversations now routinely include trade policy scenarios as a material factor in supply chain planning and product lifecycle decisions.

A multidimensional segmentation framework linking end user, technology, product, device type, and clinical application reveals differentiated value drivers across care settings and procedures

Segmentation based on end user distinguishes ambulatory surgical centers, hospitals, and specialty clinics, with ambulatory surgical centers further parsed into hospital-based and independent facilities, and hospitals differentiated across private, public, and teaching institutions; this structure highlights how care setting influences procurement cycles, capital planning, and clinical throughput imperatives, revealing divergent adoption timelines where independent ambulatory centers often prioritize rapid turnover and cost efficiency while teaching hospitals emphasize integration with training and research programs.

Technology segmentation separates electromagnetic tracking and optical tracking, with electromagnetic tracking subdivided into high frequency and low frequency approaches and optical tracking distinguished by infrared-based and laser-based implementations; these technological delineations matter because frequency characteristics, line-of-sight limitations, and susceptibility to intraoperative interference drive selection criteria for specific procedures, influencing whether a facility opts for an electromagnetic solution with robust line-insensitive performance or an optical system that offers high-resolution visualization under optimal sightlines.

Product segmentation groups accessories, navigation systems, and robotic systems, where navigation systems break down into hardware modules and software components and robotic systems split into active and passive architectures; the interplay between hardware modularity and software capabilities determines upgrade pathways and long-term service relationships, while the choice between active and passive robotic assistance reflects clinical philosophy regarding the degree of automation and surgeon control.

Type segmentation contrasts frame-based and frameless devices, with frame-based devices narrowed to stereotactic frames and frameless devices categorized into marker-based and markerless approaches; this typology matters for patient experience and procedural logistics because frame-based workflows often involve preoperative fixation and imaging coordination, whereas frameless markerless systems streamline patient preparation and can reduce anesthesia time in selected procedures.

Application segmentation includes brain surgery, ENT surgery, and spine surgery, with brain procedures further classified into deep brain stimulation and tumor resection, ENT procedures into sinus surgery and tumor surgery, and spine procedures into decompression and fusion; these clinical subdivisions underscore how device requirements vary by target anatomy, required trajectory precision, and the need for intraoperative adaptability, which in turn shapes validation studies, surgeon training programs, and post-market evidence generation strategies.

Distinct regional adoption pathways reflect infrastructure maturity, reimbursement paradigms, and localized evidence generation priorities across the Americas, EMEA, and Asia-Pacific

Regional dynamics for stereotactic surgery devices show distinct demand drivers across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each shaped by healthcare infrastructure maturity, reimbursement norms, and local regulatory environments. In the Americas, large tertiary centers and a high concentration of device innovators drive early adoption of advanced navigation and robotic systems, while ambulatory surgical centers expand uptake of frameless and markerless solutions that support high-throughput elective procedures. Transitioning from research to routine use in North America often hinges on demonstrable workflow efficiencies and alignment with procedural reimbursement.

In Europe, Middle East & Africa, heterogeneous regulatory pathways and varied hospital funding models create a mosaic of adoption patterns; several nations emphasize cost-conscious procurement and high-value bundles that include training and long-term service, whereas centers of excellence in Western Europe often pilot cutting-edge tracking and robotic hybrids. In the Asia-Pacific region, rapid hospital expansion, investment in diagnostic imaging capacity, and growing local manufacturing capabilities have accelerated adoption across both private and public hospital segments, with particular momentum in teaching hospitals that integrate stereotactic platforms into specialty program growth. Across all regions, clinical partnerships and localized evidence generation remain central to unlocking durable adoption and payer acceptance.

Competitive dynamics favor integrated navigation ecosystems, strategic partnerships, and lifecycle service monetization as core differentiators for device companies

Key company dynamics in the stereotactic devices arena center on strategic positioning along the hardware-software-service continuum, with leading firms investing in integrated navigation ecosystems rather than standalone instruments. Several incumbent device manufacturers have expanded portfolios through targeted acquisitions that add software planning suites, sensor technologies, or complementary robotic modules, while nimble innovators have focused on niche differentiation through lower-cost, high-precision tracking or novel markerless registration algorithms. This competitive mix intensifies emphasis on interoperability, regulatory compliance for software releases, and robust training programs to shorten clinician learning curves.

Partnerships between device makers, imaging vendors, and health systems are increasingly common, enabling co-development of validated workflows and real-world evidence studies. Service models are evolving from traditional warranty and maintenance contracts toward value-based agreements tied to procedural outcomes and uptime guarantees. For new entrants, success frequently depends on demonstrating clear clinical advantages in specific applications-such as deep brain stimulation trajectory accuracy or sinus surgery navigation time reduction-while incumbents leverage scale, global service networks, and established hospital relationships to protect installed-base revenue streams. Investors and strategic partners are watching closely for differentiators in software intellectual property, sensor fusion capabilities, and lifecycle monetization strategies.

Prioritize modular design, robust clinical evidence, flexible commercial models, and supply chain resilience to accelerate adoption and protect long-term value

Industry leaders seeking to capture clinical and commercial value from stereotactic surgery devices should prioritize a set of actionable moves that align product development with clinical workflows and institutional buying behavior. First, invest in modular architectures that allow incremental upgrades to hardware modules and software applications, enabling customers to protect prior investments while adopting new capabilities. Second, build stronger clinical evidence through multi-center studies that emphasize procedural efficiency, complication reduction, and reproducible accuracy; such data support procurement discussions and accelerate clinician acceptance. Third, develop flexible commercial models that combine capital, subscription, and outcomes-linked service components to address diverse hospital and ambulatory center budgets.

Additionally, focus on supply chain resilience by qualifying secondary suppliers for critical components and exploring regional manufacturing to hedge against trade disruptions. Strengthen post-market support and training programs with simulation-based curricula that shorten the learning curve and increase procedural throughput. Finally, proactively engage with regulators and payers to clarify pathways for software updates and to articulate the clinical and economic value of navigation-enabled care. Executed together, these recommendations will help leaders minimize adoption friction, protect margins, and translate technical differentiation into measurable clinical impact.

A rigorous evidence synthesis combining clinician interviews, device documentation, regulatory records, and technology assessments to validate clinical and operational insights

This research synthesizes primary qualitative interviews with clinicians, procurement leaders, and industry executives alongside a structured review of regulatory filings, peer-reviewed clinical studies, and product literature. Primary inputs included semi-structured discussions with neurosurgeons, ENT specialists, spine surgeons, and operating room managers to capture real-world workflow constraints, adoption inhibitors, and desired feature sets. Secondary analysis encompassed device manuals, regulatory approvals, and clinical trial protocols to verify technical claims and to understand evidence generation timelines. Throughout the research, source triangulation ensured consistency between reported clinical outcomes and device specifications.

Analytical methods combined thematic coding of interview transcripts to identify recurring adoption drivers with technology assessment frameworks that evaluated tracking accuracy, latency, and integration complexity. Supply chain analysis mapped critical component dependencies and logistics vulnerabilities exposed by trade policy changes. Care was taken to verify factual assertions against publicly available regulatory documents and peer-reviewed clinical literature. Where gaps in evidence existed, the analysis identified priority areas for future clinical evaluation and recommended approaches for pragmatic validation within hospital settings.

Integrated clinical platforms, validated workflows, and resilient supply strategies will determine which innovations translate into sustained clinical and commercial success

Stereotactic surgery devices are transitioning from discrete tools to integrated clinical platforms that must deliver demonstrable procedural value, seamless interoperability, and resilient supply strategies. The combined forces of technological convergence, evolving regulatory expectations for software-enabled devices, and trade-related supply chain shifts mean that stakeholders must balance innovation with practical considerations around service, training, and long-term upgradeability. Clinicians increasingly seek devices that integrate into established imaging ecosystems and that provide clear reductions in procedure complexity and variability.

For manufacturers, the path ahead requires investing in clinical evidence, building flexible commercial arrangements, and strengthening regional supply networks to mitigate policy-driven disruptions. For providers, prioritizing procurement decisions based on lifecycle value and total workflow impact rather than initial acquisition price will improve patient outcomes and operational efficiency. In sum, the community of device developers, healthcare providers, and policy makers must collaborate to ensure that technological advances translate into safer, more accessible, and more cost-effective stereotactic care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven imaging and navigation systems for real-time surgical guidance in stereotactic procedures
  • 5.2. Development of next-generation robotic arms with haptic feedback to enhance precision in neurosurgical interventions
  • 5.3. Adoption of minimally invasive stereotactic platforms for targeted treatment of movement disorders and epilepsy
  • 5.4. Emergence of cloud-based data management solutions for collaborative planning and outcome tracking in stereotactic surgery
  • 5.5. Expansion of MRI-compatible stereotactic instruments enabling intraoperative imaging for improved surgical accuracy
  • 5.6. Growing use of augmented reality overlays integrated with stereotactic frames for enhanced trajectory visualization during brain surgery

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Stereotactic Surgery Devices Market, by End User

  • 8.1. Ambulatory Surgical Centers
    • 8.1.1. Hospital-Based Ascs
    • 8.1.2. Independent Ascs
  • 8.2. Hospitals
    • 8.2.1. Private Hospitals
    • 8.2.2. Public Hospitals
    • 8.2.3. Teaching Hospitals
  • 8.3. Specialty Clinics

9. Stereotactic Surgery Devices Market, by Technology

  • 9.1. Electromagnetic Tracking
    • 9.1.1. High Frequency
    • 9.1.2. Low Frequency
  • 9.2. Optical Tracking
    • 9.2.1. Infrared Based
    • 9.2.2. Laser Based

10. Stereotactic Surgery Devices Market, by Product

  • 10.1. Accessories
  • 10.2. Navigation Systems
    • 10.2.1. Hardware Modules
    • 10.2.2. Software
  • 10.3. Robotic Systems
    • 10.3.1. Active Systems
    • 10.3.2. Passive Systems

11. Stereotactic Surgery Devices Market, by Type

  • 11.1. Frame Based Devices
    • 11.1.1. Stereotactic Frames
  • 11.2. Frameless Devices
    • 11.2.1. Marker Based
    • 11.2.2. Markerless

12. Stereotactic Surgery Devices Market, by Application

  • 12.1. Brain Surgery
    • 12.1.1. Deep Brain Stimulation
    • 12.1.2. Tumor Resection
  • 12.2. Ent Surgery
    • 12.2.1. Sinus Surgery
    • 12.2.2. Tumor Surgery
  • 12.3. Spine Surgery
    • 12.3.1. Decompression
    • 12.3.2. Fusion

13. Stereotactic Surgery Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Stereotactic Surgery Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Stereotactic Surgery Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtronic plc
    • 16.3.2. Stryker Corporation
    • 16.3.3. Zimmer Biomet Holdings, Inc.
    • 16.3.4. Elekta AB (publ)
    • 16.3.5. Brainlab AG
    • 16.3.6. Renishaw plc
    • 16.3.7. Synaptive Medical, Inc.
    • 16.3.8. Monteris Medical Corporation
    • 16.3.9. iSYS Medizintechnik GmbH
    • 16.3.10. FHC, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. STEREOTACTIC SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. STEREOTACTIC SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. STEREOTACTIC SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPT